Research Suggests Curecumin(TM) May Be an Effective Treatment for Skin Cancer

    KULA, Maui, Hawaii, May 3 /PRNewswire-FirstCall/ -- Bioponic
 Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT) today
 announced that its Curecumin(TM) (a Bioresonant Phytotherapeutic(R) form of
 curcumin in a liquid delivery system) may be an important treatment for
 Skin Cancer.
     In a recent study published in the Journal of Biological Chemistry,
 "Curcumin Suppresses AP1 Transcription Factor-dependent Differentiation and
 Activates Apoptosis in Human Epidermal Keratinocytes," conducted at the
 Departments of Physiology and Biophysics, Dermatology, Biochemistry,
 Reproductive Biology, and Oncology, at Case Western Reserve University
 School of Medicine in Cleveland, Ohio. Scientists concluded, "The
 diet-derived cancer preventive agent, curcumin, inhibits skin cancer cell
 proliferation and tumor formation ... We show that curcumin suppresses the
 differentiation agent-dependent activation of hINV gene expression and that
 an AP1 transcription factor DNA binding site in the hINV gene is required
 for this regulation ... These studies provide important insights regarding
 the mechanism whereby curcumin acts as a chemopreventive agent in normal
 human epidermis."
     According to the Skin Cancer Foundation, "Basal cell carcinoma is the
 most common form of skin cancer, and affects more than 800,000 Americans
 each year. Squamous cell carcinoma, the second most common skin cancer,
 afflicts more than 250,000 Americans each year."
     "We are particularly interested in the potential of our Curecumin(TM)
 (see http://www.curecumin.com) product to provide a viable treatment
 strategy for those with skin cancer. Especially, because the form of
 Curecumin, in a liquid delivery system, will send the formula directly to
 the skin. If proven effective, we may have an efficacious, cost effective,
 natural treatment for skin cancer sufferers. We have also included this
 important ingredient in our popular topical skin care product Hawaiian
 Healing Mist(TM)," said Steven M. Schorr, Chairman & CEO (see
 http://www.hawaiianhealingmist.com)
     Bioponic Phytoceuticals is engaged in the development, production and
 distribution of Bioresonant Phytotherapeutic(TM) products. The Company has
 developed several branded product lines (including the nasal spray: Flight
 Spray(R) (http://www.flightspray.com) and the skincare product Hawaiian
 Healing Mist(TM)). Bioponic is focused on the production of natural
 products that are used to promote health and well-being. www.bioponic.com
 Contact: Steven M. Schorr/CEO, Bioponic Phytoceuticals, info@bioponic.com,
 ph: 808-876-1711
     All statements other than statements of historical fact included in
 this press release are "forward-looking statements" within the meaning of
 federal securities laws. Such forward-looking statements are subject to a
 number of risks and uncertainties, some of which are beyond the Company's
 control.
 
 

SOURCE Bioponic Phytoceuticals, Inc.